The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions-Reference-Cited by-同舟云学术

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

Published:2002-11-27 Issue:1 Volume:99 Page:51-56
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Illei Peter B.,Ladanyi Marc,Rusch Valerie W.,Zakowski Maureen F.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma;Kitazume;Cancer (Cancer Cytopathol).,2000

2. Cytology: screening or diagnostic tool?;Turbat-Herrera;Hum Pathol.,1998

3. Diagnostic problems in serous effusions;Bedrossian;Diagn Cytopathol.,1998

4. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma;Renshaw;Chest.,1997

5. Treatment and survival in diffuse malignant pleural mesothelioma: a study of 83 cases from the Massachusetts General Hospital;Huncharek;Anticancer Res.,1996

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic Cases;The American Journal of Dermatopathology;2024-04-23

2. Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment;Annual Review of Pathology: Mechanisms of Disease;2024-01-24

3. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma;Diagnostic Cytopathology;2024-01-20

4. Updates in Management of Malignant Pleural Mesothelioma;Current Treatment Options in Oncology;2023-11-17

5. Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting;Cancer Cytopathology;2023-05